U.S. markets close in 2 hours 7 minutes
  • S&P 500

    3,846.62
    -23.67 (-0.61%)
     
  • Dow 30

    31,460.26
    +68.74 (+0.22%)
     
  • Nasdaq

    13,110.04
    -248.74 (-1.86%)
     
  • Russell 2000

    2,245.11
    +13.60 (+0.61%)
     
  • Crude Oil

    61.67
    +1.92 (+3.21%)
     
  • Gold

    1,717.20
    -16.40 (-0.95%)
     
  • Silver

    26.42
    -0.46 (-1.73%)
     
  • EUR/USD

    1.2079
    -0.0009 (-0.07%)
     
  • 10-Yr Bond

    1.4690
    +0.0540 (+3.82%)
     
  • GBP/USD

    1.3976
    +0.0019 (+0.14%)
     
  • USD/JPY

    106.9540
    +0.2440 (+0.23%)
     
  • BTC-USD

    51,209.51
    +3,391.44 (+7.09%)
     
  • CMC Crypto 200

    1,025.04
    +36.94 (+3.74%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Twist Bioscience to Present at the Jefferies Virtual Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2 at 9:30 a.m. Eastern Time.

The presentation will be webcast live and can be accessed by visiting the "Presentations" page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 90 days following the conclusion of the live event.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005267/en/

Contacts

Investor Contact:
Argot Partners
Maeve Conneighton
212-600-1902
maeve@argotpartners.com

Media Contact:
Angela Bitting
925- 202-6211
media@twistbioscience.com